Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Diethylstilbestrol in Androgen Independent Prostate Cancer
NCT00136526Phase 2Completed
- Sponsor
- University of Washington
- Start
- Dec 2002
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of docetaxel and diethylstilbestrol in prostate cancer (PCa), sponsored by University of Washington. Primary endpoint: Monthly PSA levels and scans at 10 months. Started Dec 2002; status: completed.
02
Drugs
docetaxeldiethylstilbestrol
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00136526.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00136526.